Form 4 for MRK Merck & Co.
Accepted 2023-05-05 00:00:00 ET · period of report 2023-05-03 · accession 0001127602-23-014745 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-05-05 | 2023-05-03+ | MRK | LeCointe-Cephas Lisa | SVP Chief Ethics, Com Off | F - Tax | $118.07 | -515 | 5,142 | -9% | -$60.8K |
| DM | 2023-05-05 | 2023-05-03+ | MRK | LeCointe-Cephas Lisa | SVP Chief Ethics, Com Off | M - OptEx | $118.07 | +1,502 | 5,421 | +38% | +$177.3K |
| DM | 2023-05-05 | 2023-05-03+ | MRK | LeCointe-Cephas Lisa | SVP Chief Ethics, Com Off | M - OptEx | $0.00 | -1,502 | 1,378 | -52% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-03 | F | D | 236 | $117.89 | 4,607.69 | D | — | — | |
| 2 | Common | Common Stock | 2023-05-03 | M | A | 689 | $117.89 | 4,843.69 | D | — | — | |
| 3 | Common | Common Stock | 2023-05-04 | M | A | 813 | $118.22 | 5,420.69 | D | — | — | |
| 4 | Common | Common Stock | 2023-05-04 | F | D | 279 | $118.22 | 5,141.69 | D | — | — | |
| 5 | Derivative | Restricted Stock Unit | 2023-05-04 | M | D | 813 | $0.00 | 816 | D | — · 2022-05-04 to 2024-05-04 | 813 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. (F3) These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024. |
| 6 | Derivative | Restricted Stock Unit | 2023-05-03 | M | D | 689 | $0.00 | 1,378 | D | — · 2023-05-03 to 2025-05-03 | 689 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. (F2) These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2023, 5/3/2024, and 5/3/2025. |